
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
Secondary Prevention
Author(s)John S. Banas, Jr., MD
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
Coronary Heart Disease in the United Statesalmost 28 years ago
Mechanisms of Acute Coronary Eventsalmost 28 years ago
Primary Preventionalmost 28 years ago
Pravastatin Event Reduction Analysisalmost 28 years ago
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?almost 28 years ago
Methods and Mindsets in Pharmacoeconomicsalmost 28 years ago
Issues and Controversies in Pharmacoeconomicsalmost 28 years ago
Pharmacoeconomics Perspectives: Payers, Providers, and PatientsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Top 5 Most-Read Multiple Sclerosis Articles of 2025
2
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
3
Top 5 Trending FDA Approvals of 2025
4
Long-Term Trial Shows Durable Efficacy, QOL Gains With Nirogacestat in Desmoid Tumors
5







































